Peddock Capital Advisors, LLC Seres Therapeutics, Inc. Transaction History

Peddock Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $34,878 - $57,117	-1,975 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $45,918 - $74,516	1,975 New	1,975 $48,000
Q1 2020 May 13, 2020	SELL	$2.64 - $3.82 $8,712 - $12,606	-3,300 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$2.99 - $4.42 $9,867 - $14,586	3,300 New	3,300 $11,000
Q2 2019 Aug 06, 2019	SELL	$2.28 - $7.35 $683 - $2,205	-300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $3,843 - $5,055	300	300 $5,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Peddock Capital Advisors, LLC with notifications on news.